Systematic review of 41 studies (19 RCTs, 6171 patients, meta-analysed) in axial spondyloarthritis on biologics or tsDMARDs: pooled proportion reaching ASDAS inactive disease was 0.24 at 12–24 weeks; odds of inactive disease vs low disease activity were 0.30.
Meta-analysisn = 6,171
Doumeth et al. Achieving Axial Spondyloarthritis Disease Activity Score Inactive Disease Status in Axial Spondyloarthritis in Clinical Trials: A Systematic Review and Metaanalysis